Physician

Asheesh Lal, M.D.

According to 2025 Medicare claims, Asheesh Lal, M.D. (NPI: 1841223047) practices hematology/oncology in the Columbia, SC market, with the plurality of this provider's patient population coming from Lexington, SC. This provider's primary affiliated billing organization is LEXINGTON HEALTH INC (NPI: 1932706264; TIN: 85-2276567) and primary practice location at 29169-4848.

Lal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,195 traditional Medicare patients, billed 237,903 HCPCS/CPT codes, and received $4,175,231 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,429 prescription claims across 319 beneficiaries totaling $11,032,636 in drug costs, led by Xtandi (Enzalutamide). 2023 DME data shows 44 claims. Open Payments data shows 30 records totaling $610. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,717,160 to $4,175,231. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $2,649,839 to $11,032,636. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $10,431 to $616.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	692	205,342	$1,717,160
2016	727	235,907	$2,156,414
2017	739	227,192	$1,838,842
2018	837	176,299	$1,858,319
2019	963	230,114	$2,290,979
2020	1,079	223,707	$3,102,139
2021	1,158	203,893	$3,340,773
2022	1,248	227,292	$3,728,328
2023	1,262	260,147	$4,380,275
2024	1,195	237,903	$4,175,231

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	219	1,843	$2,649,839
2016	226	1,950	$2,862,718
2017	206	1,807	$3,801,277
2018	203	1,468	$4,899,179
2019	200	1,602	$5,261,538
2020	220	1,718	$5,862,879
2021	246	1,774	$6,936,013
2022	276	1,861	$7,074,801
2023	268	1,948	$6,987,304
2024	319	2,429	$11,032,636

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	226	$32,591
2016	N/R	262	$12,724
2017	N/R	277	$10,108
2018	N/R	61	$5,220
2019	N/R	36	$2,069
2020	N/R	N/R	N/R
2021	N/R	65	$4,377
2022	N/R	N/R	N/R
2023	N/R	44	$4,437
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	279	620	$89
36415	Insertion of needle into vein for collection of blood sample	602	1,768	$8
80048	Blood test, basic group of blood chemicals (calcium, total)	532	1,352	$8
80076	Liver function blood test panel	500	1,251	$8
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	642	1,867	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	122	3,660	$1,669,318
Revlimid	Lenalidomide	99	2,688	$1,626,100
Lenalidomide	Lenalidomide	57	1,561	$807,907
Jakafi	Ruxolitinib Phosphate	39	1,170	$677,096
Tagrisso	Osimertinib Mesylate	31	930	$515,528

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	30	$610	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Asheesh Lal, M.D.?

Tedicare shows public-source Medicare data for Asheesh Lal, M.D. (NPI 1841223047), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Asheesh Lal, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Asheesh Lal, M.D.?

Asheesh Lal, M.D. is linked to LEXINGTON HEALTH INC (billing NPI 1932706264) in the available physician profile data.

Does Asheesh Lal, M.D. have Open Payments data?

Asheesh Lal, M.D. has 30 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.